Goldman Sachs’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-289,135
Closed -$4.35M 6463
2025
Q2
$4.35M Buy
289,135
+195,216
+208% +$2.85M ﹤0.01% 3547
2025
Q1
$1.41M Buy
93,919
+7,342
+8% +$109K ﹤0.01% 4428
2024
Q4
$1.25M Sell
86,577
-25,310
-23% -$452K ﹤0.01% 4659
2024
Q3
$2.19M Buy
111,887
+59,393
+113% +$1.07M ﹤0.01% 4087
2024
Q2
$899K Sell
52,494
-8,896
-14% -$164K ﹤0.01% 4478
2024
Q1
$1.03M Sell
61,390
-413,980
-87% -$6.28M ﹤0.01% 4327
2023
Q4
$8.61M Buy
475,370
+62,762
+15% +$1.14M ﹤0.01% 2670
2023
Q3
$6.99M Sell
412,608
-130,075
-24% -$1.86M ﹤0.01% 2702
2023
Q2
$6.51M Buy
542,683
+286,610
+112% +$3.91M ﹤0.01% 2864
2023
Q1
$3.33M Sell
256,073
-601,698
-70% -$9.86M ﹤0.01% 3425
2022
Q4
$12.7M Buy
857,771
+427,226
+99% +$4.67M ﹤0.01% 2365
2022
Q3
$3.81M Sell
430,545
-3,482,742
-89% -$43.8M ﹤0.01% 3382
2022
Q2
$49.5M Buy
3,913,287
+3,586,271
+1,097% +$45.7M 0.01% 1126
2022
Q1
$6.19M Sell
327,016
-256,658
-44% -$6.53M ﹤0.01% 3150
2021
Q4
$20.5M Sell
583,674
-26,384
-4% -$857K ﹤0.01% 2090
2021
Q3
$22.3M Buy
610,058
+396,026
+185% +$15.6M ﹤0.01% 1965
2021
Q2
$8.4M Sell
214,032
-39,288
-16% -$1.13M ﹤0.01% 2860
2021
Q1
$7.16M Sell
253,320
-61,875
-20% -$1.97M ﹤0.01% 2831
2020
Q4
$10.1M Sell
315,195
-203,242
-39% -$6.25M ﹤0.01% 2462
2020
Q3
$16.7M Buy
518,437
+272,827
+111% +$8.5M ﹤0.01% 1872
2020
Q2
$6.77M Buy
245,610
+45,941
+23% +$997K ﹤0.01% 2568
2020
Q1
$3.56M Sell
199,669
-81,182
-29% -$1.96M ﹤0.01% 2901
2019
Q4
$7.04M Buy
280,851
+88,153
+46% +$1.93M ﹤0.01% 2694
2019
Q3
$3.44M Buy
192,698
+24,327
+14% +$507K ﹤0.01% 3133
2019
Q2
$3.7M Sell
168,371
-5,415
-3% -$155K ﹤0.01% 3072
2019
Q1
$5.31M Sell
173,786
-35,395
-17% -$883K ﹤0.01% 2927
2018
Q4
$4.83M Buy
+209,181
New +$6.5M ﹤0.01% 2914

Other funds holding HCM

Goldman Sachs's HCM Position: Q3 2025 in Review

Goldman Sachs sold out of HUTCHMED (HCM) in Q3 2025, closing a stake of 289,135 shares — an estimated $4.35M sold.

Goldman Sachs first reported a position in HCM in Q4 2018 and held it in 27 quarters. The position peaked at $49.5M in Q2 2022. 58 funds tracked by Wall St. Rank hold HCM as of Q3 2025.

  • Goldman Sachs reported no remaining HUTCHMED position as of Q3 2025 after selling out during the quarter.
  • Goldman Sachs sold 289,135 HUTCHMED shares in Q3 2025, an estimated $4.35M.
  • Goldman Sachs first reported a position in HUTCHMED in Q4 2018 and held it in 27 quarters.
  • Goldman Sachs's HUTCHMED position peaked at $49.5M in Q2 2022.
  • 58 funds tracked by Wall St. Rank held HUTCHMED as of Q3 2025.

Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.